Clinical trial

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

NCT00551590

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo tablet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Sitagliptin tablet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Saline infusion Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Exendin(9-39) infusion Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-12-01

PhasePHASE1

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Interventions

Placebo tabletDRUG

Sitagliptin tabletDRUG

Saline infusionDRUG

Exendin(9-39) infusionDRUG

Sponsors & collaborators

Ludwig-Maximilians - University of Munichlead sponsor

Merck Sharp & Dohme LLCcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00551590 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.